Yu Leng

Yu Leng

Auto-generated profile, based on publicly available information

Yu Leng

Massachusetts General Hospital

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in JMIR Aging
Verified
Journal Article
Open access
MWMatthew West
Matthew West
YCYou Cheng
You Cheng
YHYingnan He
Yingnan He
YLYu Leng
Yu Leng
CMColin Magdamo
Colin Magdamo
SDSudeshna Das
Sudeshna Das
Background: Alzheimer disease and related dementias (ADRD) exhibit prominent heterogeneity. Identifying clinically meaningful ADRD subtypes is essential for tailoring treatments to specific patient phenotypes. Objective: We aimed to use unsupervised learning techniques on electronic health records (EHRs) from memory clinic patients to identify ADRD subtypes. Methods: We used pretrained embeddings of non-ADRD diagnosis codes (International Classification of Diseases, Ninth Revision) and large language model (LLM)–derived embeddings of clinical notes from patient EHRs. Hierarchical clustering of these embeddings was used to identify ADRD subtypes. Clusters were characterized regarding their demographic and clinical features. Results: We analyzed a cohort of 3454 patients with ADRD from a memory clinic at Massachusetts General Hospital, each with a specialist diagnosis. Clustering pretrained embeddings of the non-ADRD diagnosis codes in patient EHRs revealed the following 3 patient subtypes: one with skin conditions, another with psychiatric disorders and an earlier age of onset, and a third with diabetes complications. Similarly, using LLM-derived embeddings of clinical notes, we identified 3 subtypes of patients as follows: one with psychiatric manifestations and higher prevalence of female participants (prevalence ratio: 1.59), another with cardiovascular and motor problems and higher prevalence of male participants (prevalence ratio: 1.75), and a third one with geriatric health disorders. Notably, we observed significant overlap between clusters from both data modalities (χ24=89.4; P<.001). Conclusions: By integrating International Classification of Diseases, Ninth Revision codes and LLM-derived embeddings, our analysis delineated 2 distinct ADRD subtypes with sex-specific comorbid and clinical presentations, offering insights for potential precision medicine approaches.

6 January 2026 in The Journal of Aging Research & Lifestyle
Verified
Journal Article
Open access
YHYingnan He
Yingnan He
YLYu Leng
Yu Leng
AVAna-Maria Vranceanu
Ana-Maria Vranceanu
CRChristine Seel Ritchie
Christine Seel Ritchie
DBDeborah Blacker
Deborah Blacker
SDSudeshna Das
Sudeshna Das
Early diagnosis of Alzheimer’s disease and related dementias (AD/ADRD) is critical but often constrained by limited access to fluid and imaging biomarkers, particularly in low-resource settings. To develop and evaluate a predictive model for cognitive decline using survey-based data, with attention to model interpretability and fairness. Using data from the Mexican Health and Aging Study (MHAS), a nationally representative longitudinal survey of adults aged 50 and older (N = 4095), we developed a machine learning model to predict future cognitive scores. The model was trained on survey data from 2003 to 2012, encompassing demographic, lifestyle, and social determinants of health (SDoH) variables. A stacked ensemble approach combined five base models—Random Forest, LightGBM, XGBoost, Lasso, and K-Nearest Neighbors—with a Ridge regression meta-model. The model achieved a root-mean-square error (RMSE) of 39.25 (95 % CI: 38.12–40.52), representing 10.2 % of the cognitive score range, on a 20 % held-out test set. Features influencing predictions, included education level, age, reading behavior, floor material, mother’s education level, social activity frequency, the interaction between the number of living children and age, and overall engagement in activities. Fairness analyses revealed model biases in underrepresented subgroups within the dataset, such as individuals with 7–9 years of education. These findings highlight the potential of using accessible, low-cost SDoH survey data for predicting risk of cognitive decline in aging populations. They also underscore the importance of incorporating fairness metrics into predictive modeling pipelines to ensure equitable performance across diverse groups.

10 July 2026 in medRxiv
Verified
Preprint
Open access
PDF file
YLYu Leng
Yu Leng
Ayush NooriAyush Noori
Ayush Noori
JDJohn Robert Dickson
John Robert Dickson
ASAlberto Serrano-Pozo
Alberto Serrano-Pozo
MAMarina Avetisyan
Marina Avetisyan
SDSudeshna Das
Sudeshna Das
BACKGROUND Accurate differential diagnosis of complex neurological disorders remains challenging due to overlapping clinical features and heterogeneous disease presentations. Although large language models (LLMs) show promise in clinical reasoning, prior studies benchmark performance against clinician consensus rather than biological ground truth. A neuropathologically confirmed benchmark dataset for evaluating diagnostic AI in neurology is currently lacking. METHODS We introduce NeuroBench, a curated benchmark of complex neurological cases with neuropathologically confirmed gold-standard diagnoses, and DIAGNO, a confidence-aware LLM-based system for neurological diagnosis. NeuroBench comprises 203 retrospective case summaries from the Massachusetts General Hospital Brain Cutting Conference with corresponding autopsy-confirmed diagnoses. DIAGNO generated top-3 differential diagnoses, employing retrieval-augmented generation (RAG) for lower-confidence cases. Performance was assessed by three independent blinded adjudicators who evaluated both DIAGNO and neurologists against neuropathological ground truth. RESULTS NeuroBench encompassed 79 unique neuropathological diagnoses, spanning conditions including cerebrovascular disease, brain tumors, neurological infections, and various neurodegenerative and inflammatory disorders. DIAGNO matched or outperformed neurologists in top-3 accuracy (0.67 versus 0.63) and taxonomy-level accuracy (0.74 versus 0.66). In cases of disagreement, DIAGNO was more often correct than neurologists (29 versus 19 cases). Diagnostic concordance between DIAGNO and neurologists was high (90% agreement in top-3 predictions), even when both were incorrect, suggesting strong alignment in diagnostic reasoning. On NeuroBench, DIAGNO also outperformed GPT-4o baseline and DeepSeek R1 across all top-k accuracy metrics. In a real-world evaluation on eight complex cases with differentials from Mass General Brigham, neurologists rated DIAGNO's reasoning favorably (mean 4.03/5) across multiple dimensions of clinical utility and safety. CONCLUSIONS NeuroBench establishes neuropathological confirmation as the appropriate standard for evaluating diagnostic AI in neurology, moving beyond clinician-referenced benchmarking to define the ceiling of diagnostic accuracy. Evaluated against this standard, DIAGNO achieved expert-level diagnostic performance and received favorable clinician ratings in real-world applications, supporting its potential as a clinical decision-support tool in neurology.

7 August 2024 in JMIR Preprints
Verified
Preprint
Open access
MWMatthew West
Matthew West
YCYou Cheng
You Cheng
YHYingnan He
Yingnan He
YLYu Leng
Yu Leng
CMColin Magdamo
Colin Magdamo
SDSudeshna Das
Sudeshna Das
BACKGROUND Alzheimer disease and related dementias (ADRD) exhibit prominent heterogeneity. Identifying clinically meaningful ADRD subtypes is essential for tailoring treatments to specific patient phenotypes. OBJECTIVE We aimed to use unsupervised learning techniques on electronic health records (EHRs) from memory clinic patients to identify ADRD subtypes. METHODS We used pretrained embeddings of non-ADRD diagnosis codes (International Classification of Diseases, Ninth Revision) and large language model (LLM)–derived embeddings of clinical notes from patient EHRs. Hierarchical clustering of these embeddings was used to identify ADRD subtypes. Clusters were characterized regarding their demographic and clinical features. RESULTS We analyzed a cohort of 3454 patients with ADRD from a memory clinic at Massachusetts General Hospital, each with a specialist diagnosis. Clustering pretrained embeddings of the non-ADRD diagnosis codes in patient EHRs revealed the following 3 patient subtypes: one with skin conditions, another with psychiatric disorders and an earlier age of onset, and a third with diabetes complications. Similarly, using LLM-derived embeddings of clinical notes, we identified 3 subtypes of patients as follows: one with psychiatric manifestations and higher prevalence of female participants (prevalence ratio: 1.59), another with cardiovascular and motor problems and higher prevalence of male participants (prevalence ratio: 1.75), and a third one with geriatric health disorders. Notably, we observed significant overlap between clusters from both data modalities (χ24=89.4; P<.001). CONCLUSIONS By integrating International Classification of Diseases, Ninth Revision codes and LLM-derived embeddings, our analysis delineated 2 distinct ADRD subtypes with sex-specific comorbid and clinical presentations, offering insights for potential precision medicine approaches.